Pharmacogenomic Biomarker Information in FDA-approved Paediatric Drug Labels.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2015, v. 116, n. 5, p. 438, doi. 10.1111/bcpt.12341
- By:
- Publication type:
- Article
Works by Lee, Eui-Kyung
Results: 58
1
2
Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
- Published in:
- Asia-Pacific Psychiatry, 2018, v. 10, n. 1, p. 1, doi. 10.1111/appy.12289
- By:
- Publication type:
- Article
3
Higher prevalence of dementia in patients with schizophrenia: A nationwide population-based study.
- Published in:
- Asia-Pacific Psychiatry, 2016, v. 8, n. 2, p. 145, doi. 10.1111/appy.12239
- By:
- Publication type:
- Article
4
Out-of-pocket Medication Expenditure Burden of Elderly Koreans with Chronic Conditions.
- Published in:
- International Journal of Gerontology, 2015, v. 9, n. 3, p. 166, doi. 10.1016/j.ijge.2014.06.005
- By:
- Publication type:
- Article
5
Estimation of cost savings between 2011 and 2014 attributed to infliximab biosimilar in the South Korean healthcare market: real‐world evidence using a nationwide database.
- Published in:
- International Journal of Rheumatic Diseases, 2018, v. 21, n. 6, p. 1227, doi. 10.1111/1756-185X.13295
- By:
- Publication type:
- Article
6
Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants.
- Published in:
- Journal of Medical Economics, 2021, v. 24, n. 1, p. 589, doi. 10.1080/13696998.2021.1918922
- By:
- Publication type:
- Article
7
Evaluation of changes in the clinical benefits of oncology drugs over time following reimbursement using the ASCO-VF and the ESMO-MCBS.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 3, p. 1, doi. 10.1007/s00432-023-05587-0
- By:
- Publication type:
- Article
8
Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study-authors' response.
- Published in:
- 2019
- By:
- Publication type:
- Letter
9
Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
10
Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. 453, doi. 10.1093/jac/dky445
- By:
- Publication type:
- Article
11
Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07316-y
- By:
- Publication type:
- Article
12
Development of a transformation model to derive general population-based utility: Mapping the pruritus-visual analog scale (VAS) to the EQ-5D utility.
- Published in:
- Journal of Evaluation in Clinical Practice, 2017, v. 23, n. 4, p. 755, doi. 10.1111/jep.12711
- By:
- Publication type:
- Article
13
Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.
- Published in:
- Rheumatology International, 2015, v. 35, n. 5, p. 879, doi. 10.1007/s00296-014-3147-3
- By:
- Publication type:
- Article
14
Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database.
- Published in:
- Rheumatology International, 2013, v. 33, n. 12, p. 2985, doi. 10.1007/s00296-013-2833-x
- By:
- Publication type:
- Article
15
Medical costs for Korean patients with rheumatoid arthritis based on the national claims database.
- Published in:
- Rheumatology International, 2012, v. 32, n. 9, p. 2893, doi. 10.1007/s00296-011-2117-2
- By:
- Publication type:
- Article
16
Importance of a usual source of care in choosing low-priced generic drugs: a cross-sectional study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
17
Economic Evaluation of Penpulimab Plus Paclitaxel and Carboplatin Combination Therapy as First-Line Treatment for Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer in China.
- Published in:
- Clinical Drug Investigation, 2025, v. 45, n. 5, p. 283, doi. 10.1007/s40261-025-01439-6
- By:
- Publication type:
- Article
18
The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 8, p. 727, doi. 10.1007/s40261-018-0659-8
- By:
- Publication type:
- Article
19
Comparison of Effectiveness Between Delamanid and Bedaquiline Among Patients with Multidrug-Resistant Tuberculosis: A Markov Model Simulation Study.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 11, p. 957, doi. 10.1007/s40261-016-0443-6
- By:
- Publication type:
- Article
20
Signal detection of benzodiazepine use and risk of dementia: sequence symmetry analysis using South Korean national healthcare database.
- Published in:
- 2018
- By:
- Publication type:
- journal article
21
A benefit-risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
22
Use of injectable drugs with oral-formulation alternatives for outpatients in South Korea.
- Published in:
- Archives of Pharmacal Research, 2015, v. 38, n. 7, p. 1406, doi. 10.1007/s12272-014-0488-0
- By:
- Publication type:
- Article
23
Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach.
- Published in:
- Archives of Pharmacal Research, 2014, v. 37, n. 5, p. 662, doi. 10.1007/s12272-014-0337-1
- By:
- Publication type:
- Article
24
Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis.
- Published in:
- Orphanet Journal of Rare Diseases, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13023-022-02425-3
- By:
- Publication type:
- Article
25
Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study.
- Published in:
- Lipids in Health & Disease, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12944-023-01903-2
- By:
- Publication type:
- Article
26
Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10950-y
- By:
- Publication type:
- Article
27
Proton‐pump inhibitors and the risk of Clostridium difficile–associated diarrhea in high‐risk antibiotics users: A population‐based case‐crossover study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 4, p. 479, doi. 10.1002/pds.4745
- By:
- Publication type:
- Article
28
Current status of pharmacovigilance regulatory structures, processes, and outcomes in the Asia‐Pacific region: Survey results from 15 countries.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 3, p. 362, doi. 10.1002/pds.4717
- By:
- Publication type:
- Article
29
Sociodemographic factors influencing the use of injections in South Korean outpatient care.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 1, p. 51, doi. 10.1002/pds.3376
- By:
- Publication type:
- Article
30
Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 7, p. e2324852, doi. 10.1001/jamanetworkopen.2023.24852
- By:
- Publication type:
- Article
31
Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.906211
- By:
- Publication type:
- Article
32
Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 12, p. 2135, doi. 10.1111/jgh.14745
- By:
- Publication type:
- Article
33
Cost implications of adverse drug event-related emergency department visits - a multicenter study in South Korea.
- Published in:
- 2020
- By:
- Publication type:
- journal article
34
National reimbursement listing determinants of new cancer drugs: a retrospective analysis of 58 cancer treatment appraisals in 2007-2016 in South Korea.
- Published in:
- 2017
- By:
- Publication type:
- journal article
35
Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea.
- Published in:
- 2017
- By:
- Publication type:
- journal article
36
Visual Outcomes and Optical Quality of Accommodative, Multifocal, Extended Depth-of-Focus, and Monofocal Intraocular Lenses in Presbyopia-Correcting Cataract Surgery: A Systematic Review and Bayesian Network Meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
37
A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.736986
- By:
- Publication type:
- Article
38
Real-world effectiveness of CDK4/6 inhibitors on patients with HR+/HER2– advanced breast cancer in South Korea, focusing on underrepresented patients.
- Published in:
- Current Medical Research & Opinion, 2024, v. 40, n. 6, p. 967, doi. 10.1080/03007995.2024.2349741
- By:
- Publication type:
- Article
39
Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 205, doi. 10.1007/s40259-023-00576-8
- By:
- Publication type:
- Article
40
Factors Influencing Drug Shortages and Their Resolution in South Korean Community Pharmacies.
- Published in:
- Risk Management & Healthcare Policy, 2024, v. 17, p. 2083, doi. 10.2147/RMHP.S473859
- By:
- Publication type:
- Article
41
Cost-Effectiveness Analysis of Smoking Cessation Interventions With Behavioral Support: A Study Based on the Benefits of Smoking Cessation on Outcomes (BENESCO) Model.
- Published in:
- 2022
- By:
- Publication type:
- journal article
42
Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Immunotherapies.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 7, p. 4105, doi. 10.3390/ijerph19074105
- By:
- Publication type:
- Article
43
Development and Validation of a Trigger Tool for Identifying Drug-Related Emergency Department Visits.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 16, p. 8572, doi. 10.3390/ijerph18168572
- By:
- Publication type:
- Article
44
Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
- Published in:
- 2018
- By:
- Publication type:
- journal article
45
Comparison of partitioned survival modeling with state transition modeling approaches with or without consideration of brain metastasis: a case study of Osimertinib versus pemetrexed-platinum.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11971-x
- By:
- Publication type:
- Article
46
Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0151282
- By:
- Publication type:
- Article
47
Therapeutic efficacy of new botulinum toxin identified in CCUG 7968 strain.
- Published in:
- Applied Microbiology & Biotechnology, 2021, v. 105, n. 23, p. 8727, doi. 10.1007/s00253-021-11640-0
- By:
- Publication type:
- Article
48
Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 984, doi. 10.3390/vaccines11050984
- By:
- Publication type:
- Article
49
Quantitative Benefit–Risk Assessment of COVID-19 Vaccines Using the Multi-Criteria Decision Analysis.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2029, doi. 10.3390/vaccines10122029
- By:
- Publication type:
- Article
50
Despite the pandemic: upward trajectories of medication adherence and persistence in patients with dyslipidemia.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1488452
- By:
- Publication type:
- Article